Table 3.
Laboratory data for FNSD/CD patients according to anti-gAChR antibody serostatus.
| Anti gAChR antibody | |||
|---|---|---|---|
| Positive | Negative | P value | |
| Serum WBC count (/μl) | 5,800.0 ± 1,065.6 | 6,248.1 ± 1,645.9 | 0.317 |
| Serum CRP (mg/dl) | 0.101 ± 0.178 | 0.037 ± 0.447 | 0.147 |
| CSF cell count (/μl) | 1.25 ± 0.45 | 1.22 ± 0.47 | 0.826 |
| CSF protein (mg/dl) | 22.60 ± 6.45 | 24.40 ± 11.97 | 0.573 |
| IgG index | 0.490 ± 0.041 | 0.483 ± 0.046 | 0.597 |
| Anti nuclear antibody | 7/15 (46.7%) | 5/40 (12.5%) | 0.006 |
| Anti Tg antibody | 0/15 (0%) | 3/40 (7.5%) | NA |
| anti TPO antibody | 0/15 (0%) | 3/41 (7.3%) | NA |
| Anti GAD antibody | 0/7 (0%) | 0/25 (0%) | NA |
| Anti SS-A antibody | 1/12 (8.3%) | 0/39 (0%) | NA |
| Anti SS-B antibody | 0/13 (0%) | 0/38 (0%) | NA |
Tg, thyroglobulin; TPO, thyroid peroxidase; GAD, glutamic acid decarboxylase.